English to Russian Medical Medical: Pharmaceuticals risk management

Among males the incidence rate per 10,000,000 population-years of HR-positive, HER2- negative aBC with PIK3CA mutation was 4.3 in Italy, Germany and France, and 3.2 in UK and Spain.

In the EU (European Union) in 2008-2012 the incidence rate per 100,000 population-years among women of HR-positive HER2-negative advanced breast cancer (aBC) with PIK3CA mutation was 7.9.